RESUMO
OBJECTIVE: To evaluate acute rehabilitation practices in pediatric critical care units across Canada. DESIGN: Retrospective cohort study. SETTING: Six Canadian, tertiary care pediatric critical care units. PATIENTS/SUBJECTS: Six hundred children aged under 17 years admitted to pediatric critical care unit during a winter and summer month of 2011 with a greater than 24-hour length of stay. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary outcome of interest was the nature and timing of pediatric critical care unit rehabilitation practices.Rehabilitation was classified according to mobility and nonmobility interventions. Predictors of mobilization and the time to mobilization were evaluated through regression and time-dependent survival analyses, respectively. The most common form of rehabilitation provided in pediatric critical care unit was physical therapy (45.5% patients) followed by occupational therapy (4.5%) and speech and language therapy (1.5%). Interventions were primarily nonmobility in nature (69.7% of sessions), most frequently in the form of chest physiotherapy (42.7% of sessions). The median time to mobilization was 2 days (interquartile range, 1-6) as compared with 1 day for nonmobility interventions (interquartile range, 1-3). Only 57 patients (9.5%) received early mobilization. Regression analyses revealed that increasing age, admission during winter, neuromuscular blockade, and sedative infusions were associated with an increased likelihood of receiving mobility therapy. Increasing age was a predictor of early mobilization, while neuromuscular blockade was associated with delayed mobilization. No significant differences in adverse events were found between nonmobility and mobility interventions. CONCLUSIONS: Only half of the children receive rehabilitation while in the pediatric critical care unit, and when it occurs, therapy is primarily focused on respiratory function. Mobilization appears to be reserved for at-risk children who were muscle relaxed and sedated; however, its implementation in these patients is delayed. Future pediatric-specific research is essential to identify patients at risk and to understand treatment priorities and rehabilitation strategies to improve functional recovery in critically ill children.
Assuntos
Cuidados Críticos/métodos , Estado Terminal/reabilitação , Deambulação Precoce/estatística & dados numéricos , Fatores Etários , Canadá , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Bloqueio Neuromuscular , Terapia Ocupacional/estatística & dados numéricos , Avaliação de Resultados da Assistência ao Paciente , Modalidades de Fisioterapia/estatística & dados numéricos , Padrões de Prática Médica , Estudos Retrospectivos , Estações do Ano , Fonoterapia/estatística & dados numéricos , Fatores de Tempo , CaminhadaRESUMO
OBJECTIVE: Limited evidence exists on the use of corticosteroids in pediatric shock. We sought to determine physicians' practices and beliefs with regard to the management of pediatric shock. DESIGN: Cross-sectional, Internet-based survey. SETTING: Canada. SUBJECTS: Physicians identified as practicing pediatric intensive care in any of 15 academic centers. MEASUREMENTS AND MAIN RESULTS: Seventy of 97 physicians (72.2%) responded. Physicians stated that they were more likely to prescribe steroids for septic shock than for shock following cardiac surgery (odds ratio, 1.9 [95% CI, 0.9-4.3]) or trauma (odds ratio, 11.46 [95% CI, 2.5-51.2]), and 91.4% (64/70) would administer steroids to patients who had received 60 cc/kg of fluid and two or more vasoactive medications. Thirty-five percent of respondents (25/70) reported that they rarely or never conducted adrenal axis testing before giving steroids to patients in shock. Eighty-seven percent of respondents (61/70) stated that the role of steroids in the treatment of fluid and/or vasoactive drug-dependent shock needed to be clarified and that 84.3% would be willing to randomize patients into a trial of steroid efficacy who were fluid resuscitated and on one high-dose vasoactive medication. However, 74.3% stated that they would start open-label steroids in patients who required two high-dose vasoactive medications. CONCLUSIONS: This survey provides information on the stated beliefs and practices of pediatric critical care physicians with regard to the use of steroids in fluid and/or vasoactive drug-dependent shock. Clinicians feel that the role of steroids in shock still requires clarification and that they would be willing to randomize patients into a trial. This survey may be useful as an initial framework for the development of a future trial on the use of steroids in pediatric shock.
Assuntos
Corticosteroides/uso terapêutico , Atitude do Pessoal de Saúde , Fármacos Cardiovasculares/efeitos adversos , Hidratação/efeitos adversos , Padrões de Prática Médica/estatística & dados numéricos , Choque Séptico/tratamento farmacológico , Testes de Função do Córtex Suprarrenal/estatística & dados numéricos , Canadá , Criança , Estudos Transversais , Humanos , Unidades de Terapia Intensiva Pediátrica , Ensaios Clínicos Controlados Aleatórios como Assunto , Choque Séptico/etiologia , Inquéritos e QuestionáriosRESUMO
PURPOSE: Consent for research is a difficult and unpredictable process in pediatric critical care populations. The objectives of this study were to describe consent rates in pediatric critical care research and their association with patient, legal guardian, consent process, and study design-related factors. METHODS: A prospective, cohort study was conducted from 2009 to 2010 in six tertiary care pediatric intensive care units (PICU) in Canada with legal guardians of patients who were approached for consent for any ongoing PICU research study. Data were recorded on details of the consent process for all consent encounters. RESULTS: We recorded 271 consent encounters. The overall consent rate was 80.1% (217/271). We observed higher consent rates when the research assistant was introduced by a member of the clinical team prior to approaching the family (89.7 vs. 77.7%; P = 0.04). Legal guardians of cardiac surgery patients were less likely to provide consent than those of all other patients (75.3 vs. 86.0%; P = 0.03). There was no difference in consent rates between therapeutic (117/145, 80.7%) versus non-therapeutic studies (100/126, 79.4%; P = 0.88). CONCLUSION: This study provides future researchers with consent data for determination of recruitment rates, sample sizes, budget estimations, and study timelines. Future pediatric critical care studies should consider incorporating the lower consent rates in cardiac surgery patients and routine introduction of the research assistant to the family by a member of the patient's care team into their study designs. The potential influence of parental factors on consent rates in pediatric critical care studies requires further research.
Assuntos
Pesquisa Biomédica , Consentimento Livre e Esclarecido/estatística & dados numéricos , Unidades de Terapia Intensiva Pediátrica , Canadá , Pré-Escolar , Estudos de Coortes , Humanos , Lactente , Estudos Prospectivos , ProcuradorRESUMO
BACKGROUND: Accurate and reliable evaluation of cardiac index (CI) in critically ill pediatric patients can optimize their management. Although validated, noninvasive ultrasound measurement techniques have been previously shown to be unreliable because of observer variability. OBJECTIVE: To confirm intra- and inter-observer reliability when using the noninvasive USCOM(®) in healthy anesthetized children. METHODS: Prospective observational study at the Children's Hospital of Eastern Ontario, Ottawa, included newborns to 12 years of age undergoing elective surgery or magnetic resonance imaging. The USCOM(®) was used to assess CI via aortic flow with a trans-sternal approach. Two trained observers were responsible for taking two measurements of CI each at steady state in randomized succession after stable depth of anesthesia was achieved. RESULTS: Fifty-nine patients were included. Forty-seven (80%) were between 3 and 7 years old, with 57% male. The mean difference ± sd for repeat CI measurements by each of two observers was 0.11 ± 0.47 and 0.05 ± 0.65 l·min(-1) ·m(-2) , respectively. Intra-observer reliability for these repeat measurements by each observer determined by Lin's concordance correlation coefficient was 0.92 and 0.85, respectively. The mean difference ± sd between observers was 0.16 ± 0.59 l·min(-1) ·m(-2) , and Lin's concordance correlation coefficient was 0.87. The two observers subjectively rated measurements as 'Difficult' or 'Very difficult' only 14% (16/118) and 3% (4/118) of the time, respectively. No adverse events were reported. CONCLUSION: This study confirms that the USCOM(®) is relatively easy to use and reliable in healthy children when operated by trained users.
Assuntos
Anestesia , Débito Cardíaco/fisiologia , Ecocardiografia/instrumentação , Ecocardiografia/métodos , Monitorização Intraoperatória/instrumentação , Monitorização Intraoperatória/métodos , Anestesia por Inalação , Anestésicos Inalatórios , Pressão Sanguínea/efeitos dos fármacos , Criança , Pré-Escolar , Competência Clínica , Estudos de Coortes , Ecocardiografia/efeitos adversos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Éteres Metílicos , Variações Dependentes do Observador , Estudos Prospectivos , Reprodutibilidade dos Testes , Sevoflurano , Termodiluição/métodosRESUMO
RATIONALE: Adrenal insufficiency is a clinical condition associated with fluid- and catecholamine-resistant hypotension. OBJECTIVES: The objectives of this study were to determine the prevalence of adrenal insufficiency, risk factors and potential mechanisms for its development, and its association with clinically important outcomes in critically ill children. METHODS: A prospective, cohort study was conducted from 2005 to 2008 in seven tertiary-care, pediatric intensive care units in Canada on patients up to 17 years of age with existing vascular access. Adrenocorticotropic hormone stimulation tests (1 microg) were performed and adrenocorticotropic hormone levels measured in all participants. MEASUREMENTS AND MAIN RESULTS: A total of 381 patients had adrenal testing on admission. The prevalence of adrenal insufficiency was 30.2% (95% confidence interval, 25.9-35.1). Patients with adrenal insufficiency had higher baseline cortisol levels (28.6 microg/dl vs. 16.7 microg/dl, P < 0.001) and were significantly older (11.5 yr vs. 2.3 yr, P < 0.001) than those without adrenal insufficiency. Adrenal insufficiency was associated with an increased need for catecholamines (P < 0.001) and more fluid boluses (P = 0.026). The sensitivity and specificity of the low-dose adrenocorticotropic hormone stimulation test were 100% and 84%, respectively. CONCLUSIONS: Adrenal insufficiency occurs in many disease conditions in critically ill children and is associated with an increased use of catecholamines and fluid boluses. It is likely multifactorial in etiology and is associated with high baseline cortisol levels. Further research is necessary to determine which of these critically ill children are truly cortisol deficient before any treatment recommendations can be made.
Assuntos
Insuficiência Adrenal/epidemiologia , Estado Terminal , Adolescente , Insuficiência Adrenal/diagnóstico , Insuficiência Adrenal/terapia , Hormônio Adrenocorticotrópico/sangue , Fatores Etários , Canadá , Procedimentos Cirúrgicos Cardíacos/estatística & dados numéricos , Catecolaminas/uso terapêutico , Criança , Pré-Escolar , Feminino , Hidratação , Humanos , Hidrocortisona/sangue , Lactente , Unidades de Terapia Intensiva Pediátrica , Masculino , Prevalência , Estudos Prospectivos , Fatores de Risco , Sensibilidade e Especificidade , Ferimentos e Lesões/epidemiologiaRESUMO
RATIONALE: Vasopressin has been proposed as a potent vasoactive agent in the treatment of vasodilatory shock in adults and children. The objective of this trial was to evaluate the efficacy and safety of vasopressin as an adjunctive agent in pediatric vasodilatory shock. METHODS: In this multicenter, double-blind trial, children with vasodilatory shock were randomized to receive low-dose vasopressin (0.0005-0.002 U/kg/min) or placebo in addition to open-label vasoactive agents. Vasoactive infusions were titrated to clinical endpoints of adequate perfusion. The primary outcome was time to vasoactive-free hemodynamic stability. Secondary outcomes included mortality, organ-failure-free days, length of critical care unit stay, and adverse events. MEASUREMENTS AND MAIN RESULTS: Sixty-five of 69 children (94%) who were randomized received the study drug (33 vasopressin, 32 placebo) and were included in the analysis. There was no significant difference in the primary outcome between the vasopressin and placebo groups (49.7 vs. 47.1 hours; P = 0.85). There were 10 deaths (30%) in the vasopressin group and five (15.6%) in the placebo group (relative risk, 1.94; 95% confidence interval, 0.75-5.05; P = 0.24). There were no significant differences with respect to organ failure-free days (22 vs. 25.5 days; P = 0.11), ventilator-free days (16.5 23 days; P = 0.15), length of stay (8 vs. 8.5 days; P = 0.93), or adverse event rate ratios (12.0%; 95% confidence interval, -2.6 to 26.7; P = 0.15). CONCLUSIONS: Low-dose vasopressin did not demonstrate any beneficial effects in this pediatric trial. Although not statistically significant, there was a concerning trend toward increased mortality. Clinical trial registered with www.controlled-trials.com (ISRCTN11597444).
Assuntos
Arginina Vasopressina/uso terapêutico , Choque/tratamento farmacológico , Vasoconstritores/uso terapêutico , Adolescente , Arginina Vasopressina/efeitos adversos , Pressão Sanguínea/efeitos dos fármacos , Criança , Pré-Escolar , Método Duplo-Cego , Feminino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Insuficiência de Múltiplos Órgãos/prevenção & controle , Análise de Sobrevida , Resultado do Tratamento , Vasoconstritores/efeitos adversosRESUMO
BACKGROUND: Hypothermia therapy improves survival and the neurologic outcome in animal models of traumatic brain injury. However, the effect of hypothermia therapy on the neurologic outcome and mortality among children who have severe traumatic brain injury is unknown. METHODS: In a multicenter, international trial, we randomly assigned children with severe traumatic brain injury to either hypothermia therapy (32.5 degrees C for 24 hours) initiated within 8 hours after injury or to normothermia (37.0 degrees C). The primary outcome was the proportion of children who had an unfavorable outcome (i.e., severe disability, persistent vegetative state, or death), as assessed on the basis of the Pediatric Cerebral Performance Category score at 6 months. RESULTS: A total of 225 children were randomly assigned to the hypothermia group or the normothermia group; the mean temperatures achieved in the two groups were 33.1+/-1.2 degrees C and 36.9+/-0.5 degrees C, respectively. At 6 months, 31% of the patients in the hypothermia group, as compared with 22% of the patients in the normothermia group, had an unfavorable outcome (relative risk, 1.41; 95% confidence interval [CI], 0.89 to 2.22; P=0.14). There were 23 deaths (21%) in the hypothermia group and 14 deaths (12%) in the normothermia group (relative risk, 1.40; 95% CI, 0.90 to 2.27; P=0.06). There was more hypotension (P=0.047) and more vasoactive agents were administered (P<0.001) in the hypothermia group during the rewarming period than in the normothermia group. Lengths of stay in the intensive care unit and in the hospital and other adverse events were similar in the two groups. CONCLUSIONS: In children with severe traumatic brain injury, hypothermia therapy that is initiated within 8 hours after injury and continued for 24 hours does not improve the neurologic outcome and may increase mortality. (Current Controlled Trials number, ISRCTN77393684 [controlled-trials.com].).